After observing that DIO1 acts to attenuate ovarian cancer cell proliferation, together with its decreased expression in HGSOC compared to normal cells, we examined the outcome of lowering this protein by direct catalytic inhibition or silencing the DIO1 enzyme. Here, DIO1 is linked to ovarian carcinoma.